CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.

CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of the struggling healthcare giant. The company said Monday that it expanded its board to 16 members following “productive discussions” with shareholder Glenview Capital Management.

CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.